Respectfully disagree. RXSFD started in 2010, and as you know this tech goes back allot further. "Biometrics" is not as novel as it once was , and now we have the chip in CC cards. Would like to talk to Dr. Jurson and see why he let the patent Lapse, and I am still waiting for disclosure on cost to RXSFD shareholders. Managing expenses is key with no profits.
A strategy of taking a product "off the market" which is your only source of revenue leaves more question than answers.
Plug into the performa the GM, and how many RX safes it will take just to cover one salary here. But as you know, no BRICKS and MORTAR here and guessing the Minimums from China are 100. Other question, no inventory that close to CVS deal as of 9/30.Puzzling. Wouldn't have taken that chance.
News 
Market Data 
Discover 
